StockNews.com assumed coverage on shares of Galmed Pharmaceuticals (NASDAQ:GLMD – Free Report) in a report published on Sunday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Separately, Maxim Group upgraded Galmed Pharmaceuticals from a hold rating to a buy rating in a research report on Monday, July 24th. View Our Latest Stock […]
StockNews.com initiated coverage on shares of Galmed Pharmaceuticals (NASDAQ:GLMD – Free Report) in a research report sent to investors on Saturday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Separately, Maxim Group raised shares of Galmed Pharmaceuticals from a hold rating to a buy rating in a report on Monday, July 24th. […]
Galmed Pharmaceuticals (NASDAQ:GLMD) Coverage Initiated by Analysts at StockNews com themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
StockNews.com started coverage on shares of Galmed Pharmaceuticals (NASDAQ:GLMD – Free Report) in a report released on Monday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Galmed Pharmaceuticals Stock Performance Shares of NASDAQ GLMD opened at $2.56 on Monday. Galmed Pharmaceuticals has a fifty-two week low of $2.52 and a fifty-two […]
StockNews.com assumed coverage on shares of Galmed Pharmaceuticals (NASDAQ:GLMD – Free Report) in a note issued to investors on Monday. The firm set a “sell” rating on the biopharmaceutical company’s stock. Galmed Pharmaceuticals Price Performance Shares of GLMD stock opened at $3.05 on Monday. The stock has a market capitalization of $5.12 million, a PE […]